{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:57:12Z","timestamp":1793649432382,"version":"4.5.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022299","name":"School of Medicine, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43006930"],"award-info":[{"award-number":["43006930"]}],"id":[{"id":"10.13039\/501100022299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43007613"],"award-info":[{"award-number":["43007613"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.intimp.2026.116173","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:39:50Z","timestamp":1769006390000},"page":"116173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["MiR-146a-armed exosomes reverse immunosuppressive networks in NSCLC by dual-targeting of MYD88\/STAT3 and PD-L1 axes"],"prefix":"10.1016","volume":"172","author":[{"given":"Mina","family":"Alimohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Hajivalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mortaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40364-022-00444-7","article-title":"Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives","volume":"11","author":"Godoy","year":"2023","journal-title":"Biomark. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0010","article-title":"Overexpression of DAPK1 and Beclin1 under oxygen and glucose deprivation conditions promotes excessive autophagy and apoptosis in A549 cells","volume":"2","author":"Wu","year":"2023","journal-title":"MedComm \u2013 Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116173_bb0015","article-title":"CD47 expression in non-small cell lung cancer and its relationship with tumor-associated macrophage infiltration","volume":"19","author":"Zhang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116173_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.905947","article-title":"Recent advancements of monotherapy, combination, and sequential treatment of EGFR\/ALK-TKIs and ICIs in non\u2013small cell lung cancer","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2026.116173_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1366260","article-title":"Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges","volume":"15","author":"Xiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116173_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/exd.14716","article-title":"Resistance to immune checkpoint inhibitors and the tumor microenvironment","volume":"32","author":"Kawashima","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0040","first-page":"62","article-title":"Breaking boundaries: chronic diseases and the frontiers of immune microenvironments","volume":"1","author":"Li","year":"2025","journal-title":"Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2026.116173_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12032-025-02608-5","article-title":"Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer","volume":"42","author":"Fatima","year":"2025","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116173_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052805","article-title":"miRNAs in Cancer (review of literature)","volume":"23","author":"Smolarz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.116173_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat. Rev. Genet."},{"issue":"7","key":"10.1016\/j.intimp.2026.116173_bb0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/genes14071375","article-title":"miRNAs: potential as biomarkers and therapeutic targets for Cancer","volume":"14","author":"Chakrabortty","year":"2023","journal-title":"Genes"},{"issue":"16","key":"10.1016\/j.intimp.2026.116173_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612767","article-title":"MiRNA-146a-a key player in immunity and diseases","volume":"24","author":"Gilyazova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116173_bb0075","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"miR-146a suppresses invasion of pancreatic cancer cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116173_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101654","article-title":"MiR-146a suppresses the expression of CXCR4 and alters survival, proliferation and migration rate in colorectal cancer cells","volume":"73","author":"Afshar-Khamseh","year":"2021","journal-title":"Tissue Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13046-020-01761-1","article-title":"Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116173_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060317","article-title":"miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2026.116173_bb0095","first-page":"3643","article-title":"Effect and mechanism of miR-146a on malignant biological behaviors of lung adenocarcinoma cell line","volume":"19","author":"Yuan","year":"2020","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.intimp.2026.116173_bb0100","first-page":"2650","article-title":"MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer","volume":"21","author":"Yuwen","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0110","article-title":"The miR-146a SNP Rs2910164 and miR-155 SNP rs767649 are risk factors for non-small cell lung Cancer in the Iranian population","volume":"2020","author":"Dezfuli","year":"2020","journal-title":"Can. Respir. J."},{"issue":"5","key":"10.1016\/j.intimp.2026.116173_bb0115","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","article-title":"MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins","volume":"290","author":"Park","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2026.116173_bb0120","first-page":"5033","article-title":"Multiple roles of microRNA-146a in immune responses and hepatocellular carcinoma","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.intimp.2026.116173_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood.2019002045","article-title":"Myeloid cell\u2013targeted miR-146a mimic inhibits NF-\u03baB\u2013driven inflammation and leukemia progression in vivo","volume":"135","author":"Su","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/15384101.2014.977112","article-title":"miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression","volume":"14","author":"Sun","year":"2015","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0135","first-page":"34","article-title":"MicroRNA-146a inhibits progression and immune evasion in diffuse large B-cell lymphomas by targeting programmed cell death ligand 1","volume":"22","author":"Li","year":"2025","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.intimp.2026.116173_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.omto.2023.09.001","article-title":"miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8(+) T cell infiltration","volume":"31","author":"Chen","year":"2023","journal-title":"Mol Ther Oncolytics."},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2009-06-225987","article-title":"An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes","volume":"115","author":"Curtale","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55100-2","article-title":"Elevated expression of miR-146a correlates with high levels of immune cell exhaustion markers and suppresses cellular immune function in chronic HIV-1-infected patients","volume":"9","author":"Yu","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12964-023-01103-6","article-title":"A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"40","key":"10.1016\/j.intimp.2026.116173_bb0160","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1021\/acsnano.4c09190","article-title":"Tumor microenvironment-derived exosomes: a double-edged sword for advanced T cell-based immunotherapy","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.intimp.2026.116173_bb0165","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/pharmaceutics17101336","article-title":"Exosome-based drug delivery: a next-generation platform for cancer, infection, neurological and immunological diseases, gene therapy and regenerative medicine","volume":"17","author":"Serrano","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12951-021-00986-2","article-title":"Artificial exosomes for translational nanomedicine","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0175","article-title":"The future of Cancer therapy","volume":"1","author":"Chen","year":"2025","journal-title":"Nanomater. Tumor Microenviron. iMetaMed."},{"issue":"8","key":"10.1016\/j.intimp.2026.116173_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.intimp.2026.116173_bb0185","article-title":"Tumor-derived exosomes enriched by miRNA-124 promote anti-tumor immune response in CT-26 tumor-bearing mice","volume":"8","author":"Rezaei","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0190","article-title":"Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo","volume":"312","author":"Zhang","year":"2017","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.intimp.2026.116173_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112115","article-title":"Dual role of mir-146a in non-small cell lung cancer progression: molecular mechanisms and clinical potential","volume":"136","author":"Alimohammadi","year":"2025","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1039\/C9NR09011H","article-title":"Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer","volume":"12","author":"Nie","year":"2020","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.intimp.2026.116173_bb0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12032-022-01685-0","article-title":"Engineering tumor-derived small extra cellular vesicles to encapsulate miR-34a, effectively inhibits 4T1 cell proliferation, migration, and gene expression","volume":"39","author":"Hajivalili","year":"2022","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40199-021-00400-0","article-title":"Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition","volume":"29","author":"Hosseini","year":"2021","journal-title":"Daru"},{"issue":"4","key":"10.1016\/j.intimp.2026.116173_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1533","article-title":"miR-146a-5p: expression, regulation, and functions in cancer","volume":"10","author":"Iacona","year":"2019","journal-title":"Wiley Interdiscip Rev RNA."},{"issue":"33","key":"10.1016\/j.intimp.2026.116173_bb0220","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2026.116173_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in Cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0230","article-title":"Clinico-pathological importance of miR-146a in lung Cancer","volume":"11","author":"Wani","year":"2021","journal-title":"Diagnostics (Basel)."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0235","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1038\/ncomms8321","article-title":"Exosome-delivered microRNAs modulate the inflammatory response to endotoxin","volume":"6","author":"Alexander","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0240","doi-asserted-by":"crossref","first-page":"17350","DOI":"10.1038\/s41598-018-35338-y","article-title":"miR-146a regulates the crosstalk between intestinal epithelial cells, microbial components and inflammatory stimuli","volume":"8","author":"Anzola","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2026.116173_bb0245","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/cells9051303","article-title":"Lung tumor cell-derived exosomes promote M2 macrophage polarization","volume":"9","author":"Pritchard","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116173_bb0250","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221106998","article-title":"Hypoxic tumor-derived exosomes induce M2 macrophage polarization via PKM2\/AMPK to promote lung Cancer progression","volume":"31","author":"Zhou","year":"2022","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12957-022-02706-y","article-title":"Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1","volume":"20","author":"Jin","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116173_bb0260","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41401-022-00902-w","article-title":"Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy","volume":"43","author":"Mukherjee","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.intimp.2026.116173_bb0265","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/cancers11121979","article-title":"Engineered extracellular vesicles as a reliable tool in Cancer nanomedicine","volume":"11","author":"Susa","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.intimp.2026.116173_bb0270","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.bbamem.2014.07.026","article-title":"Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro","volume":"1838","author":"Smyth","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.intimp.2026.116173_bb0275","first-page":"533","article-title":"Exosome-based Cancer therapy: implication for targeting Cancer stem cells","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0280","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mdr2.70022","article-title":"The dual role of exosomes in the tumor microenvironment: from pro-tumorigenic Signaling to immune modulation","volume":"1","author":"Li","year":"2025","journal-title":"Med. Research."},{"issue":"17","key":"10.1016\/j.intimp.2026.116173_bb0285","doi-asserted-by":"crossref","first-page":"13894","DOI":"10.18632\/oncotarget.24532","article-title":"Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer","volume":"9","author":"Panigrahi","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2016.04.024","article-title":"Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity","volume":"377","author":"De Veirman","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116173_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9012152","article-title":"Multiple myeloma-derived exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a","volume":"2017","author":"Cheng","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.intimp.2026.116173_bb0300","doi-asserted-by":"crossref","first-page":"1073947","DOI":"10.1155\/2017\/1073947","article-title":"Tumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspective","volume":"2017","author":"Chen","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2026.116173_bb0305","article-title":"MicroRNA regulation in human CD8+ T cell subsets \u2013 cytokine exposure alone drives miR-146a expression","volume":"12(1):292","author":"Sheppard","year":"2014","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0310","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2009-06-225987","article-title":"An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes","volume":"115","author":"Curtale","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116173_bb0315","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3389\/fimmu.2018.01256","article-title":"Dysregulated MicroRNA involvement in multiple sclerosis by induction of T helper 17 cell differentiation","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116173_bb0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.intimp.2017.10.003","article-title":"Elevated expression of miR-146, miR-139 and miR-340 involved in regulating Th1\/Th2 balance with acute exposure of fine particulate matter in mice","volume":"54","author":"Hou","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"18","key":"10.1016\/j.intimp.2026.116173_bb0325","doi-asserted-by":"crossref","first-page":"10536","DOI":"10.3390\/ijms231810536","article-title":"Micro-players of great significance\u2014host microRNA signature in viral infections in humans and animals","volume":"23","author":"Ostrycharz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116173_bb0330","series-title":"Cancer Immunology: The Immune System and Tumor","first-page":"529","article-title":"Pro-tumorigenic and anti-tumorigenic roles of pro-inflammatory cytokines in Cancer","author":"Tahmasebi","year":"2025"},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.116173_bb0340","doi-asserted-by":"crossref","first-page":"1476644","DOI":"10.3389\/fimmu.2025.1476644","article-title":"Current status of cytokine-induced killer cells and combination regimens in breast cancer","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116173_bb0350","doi-asserted-by":"crossref","first-page":"0723","DOI":"10.34133\/research.0723","article-title":"Natural killer cell immune checkpoints and their therapeutic targeting in Cancer treatment","volume":"8","author":"Lin","year":"2025","journal-title":"Research"},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017014","article-title":"Transcriptional profiling of peripheral blood mononuclear cells in pancreatic Cancer patients identifies novel genes with potential diagnostic utility","volume":"6","author":"Baine","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2026.116173_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064456","article-title":"The effect of lung Cancer on cytokine expression in peripheral blood mononuclear cells","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.116173_bb0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/08820139.2020.1828454","article-title":"Dysregulated expression of miR-146a and its associated immune effectors in peripheral blood mononuclear cells of Esophageal carcinoma patients","volume":"51","author":"Nariman-Saleh-Fam","year":"2022","journal-title":"Immunol. Investig."},{"issue":"5","key":"10.1016\/j.intimp.2026.116173_bb0370","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/0008-5472.CAN-16-1373","article-title":"IL6 Signaling in peripheral blood T cells predicts clinical outcome in breast Cancer","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116173_bb0375","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116173_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.715677","article-title":"Evaluation expression of miR-146a and miR-155 in non-small-cell lung cancer patients","volume":"11","author":"Dezfuli","year":"2021","journal-title":"Front. Oncol."},{"issue":"41","key":"10.1016\/j.intimp.2026.116173_bb0385","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/onc.2016.34","article-title":"The tumor microenvironment in esophageal cancer","volume":"35","author":"Lin","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0390","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","article-title":"A novel methylation-based model for prognostic prediction in lung adenocarcinoma","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Genomics"},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0395","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cpan.2024.12.001","article-title":"Emerging trends and hot topics in the application of multi-omics in drug discovery: a bibliometric and visualized study","volume":"21","author":"Wang","year":"2024","journal-title":"Curr. Pharm. Anal."},{"issue":"1","key":"10.1016\/j.intimp.2026.116173_bb0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","article-title":"Advances in drug discovery based on network pharmacology and omics technology","volume":"21","author":"Liu","year":"2024","journal-title":"Curr. Pharm. Anal."},{"issue":"3","key":"10.1016\/j.intimp.2026.116173_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.130","article-title":"HPVTIMER: a shiny web application for tumor immune estimation in human papillomavirus-associated cancers","volume":"2","author":"Liu","year":"2023","journal-title":"Imeta"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:55:59Z","timestamp":1776164159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":79,"alternative-id":["S1567576926000160"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116173","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-146a-armed exosomes reverse immunosuppressive networks in NSCLC by dual-targeting of MYD88\/STAT3 and PD-L1 axes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116173"}}